A
Altos Labs
Biotechnology company dedicated to unraveling the deep biology of cellular rejuvenation programming
At a glance
- Founded
- 2021
- Headquarters
- Los Altos, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Decacorn$10B+ valuation tier
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
- YMYuri Milner
ARCH Venture Partners- JBJeff Bezos
Bezos Expeditions
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
13 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Altos Labs was the backer or acquirer, 2025–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
1 deals across Altos Labs's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Altos Labs's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Altos Labs on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Altos Labs on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

